← Back to all trials
Completed
NCT05715047
Intervention for Fatigue in HCT Recipients
Conditions: Hematologic Cancer, Hematologic Malignancy
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 66
Sponsor: Massachusetts General Hospital
Location: Massachusetts General Hospital Cancer Center Boston Massachusetts
Summary
The purpose of this study is to assess whether a cognitive-behavioral therapy (CBT) for fatigue intervention is acceptable, feasible, and effective at managing fatigue and improving quality of life for patients following hematopoietic stem cell transplant (HCT).
Eligibility Criteria
Inclusion Criteria
* adult patients (≥ 18 years)
* have the ability to speak and read English
* have undergone autologous or allogeneic transplant \> 6 months prior to enrollment
* no evidence of disease relapse requiring therapy
* no new other malignancy requiring therapy after transplant
* report moderate to severe fatigue in the past week (FSI average severity item rating ≥ 4 of 0-10)
* are currently receiving their care at the MGH Blood and Marrow Transplant Clinic
Exclusion Criteria
* Patients with active cognitive impairment or uncontrolled psychiatric illness such as schizophrenia that the treating clinician believes prohibits informed consent or participation in the intervention
* Patients already receiving CBT care
* Patients living with untreated sleep apnea
* Patients with hypoxemia requiring oxygen supplementation
Source: ClinicalTrials.gov (NCT05715047). StuddyBuddy aggregates publicly available trial information.